Posts

Oncolytics Biotech Secures New U.S. Patent Protecting Commercial Manufacturing of Pelareorep into 2044

on

Supreme Court sides with Hikma in 'skinny label' case

on

Mindpeak Secures First Patent for Advanced AI Method in Digital Pathology

on

German Court Blocks Merck's Subcutaneous Keytruda Over Patent Dispute with Halozyme

on

Closed Loop Medicine Secures Additional Key GLP-1 Patent for Its AI-Based Dosing Platform: Powering Personalized, Direct-to-Patient Therapies

on

Moderna Wins UK Appeals Court in Covid-19 Patent Case Against Pfizer/BioNTech

on

Ignoring China's Biotech Industry Is No Longer an Option: Recent Developments and Implications

on

BioNTech Acquires CureVac to Advance mRNA Cancer Therapies and End Patent Disputes

on

Federal Appeals Court Revives CRISPR Patent Dispute Between Broad Institute and University of California

on

Halozyme sues Merck over subcutaneous Keytruda as licensing talks fall through

on

Sandoz Challenges Amgen in Antitrust Lawsuit to Launch Enbrel Biosimilar in the U.S.

on

Biopharma Layoff Trends in Q1 2025 and Outlook for Q2

on

A closer look at pharmas top patent losses in 2025

on

AstraZeneca Inks $1.35B Deal with Alteogen for Subcutaneous Cancer Drugs Amid Industry Patent Disputes

on

Patent Dispute Erupts Over Merck's Injectable Keytruda

on

Amgen and Celltrion Reach Settlement in Denosumab Patent Litigation, Paving Way for Mid-2025 Biosimilar Launch

on